Siemens Healthineers AG (SMMNY) had positive earnings with growth in most regions and notable product innovations in 2024. However, challenges in China, slower diagnostics growth, and geopolitical tensions present concerns. Executives address margin impacts and tariff readiness in Q&A.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing